Tumor volume and cancer stem cell expression as prognostic markers for high-dose loco-regional failure in head and neck squamous cell carcinoma - a DAHANCA 19 study
CONCLUSION: Tumor volume, p16, and CSC markers are potential biomarkers for HDF for patients with HNSCC treated with (C-)RT. Lower expression of CSC in p16+ OPSCC may contribute to better tumor control.PMID:38341096 | DOI:10.1016/j.radonc.2024.110149
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - Category: Radiology Authors: Morten Horsholt Kristensen Mia Kristina S ørensen Trine Tramm Jan Alsner Brita Singers S ørensen Christian Maare J ørgen Johansen Hanne Primdahl Åse Bratland Claus Andrup Kristensen Maria Andersen Jacob Kinggaard Lilja-Fischer Anne Ivalu Sander Holm E Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Denmark Health | Head and Neck Cancer | HNSCC | Hypopharyngeal Cancer | Laryngeal Cancer | Oral Cancer | Oral Cavity Cancer | Oropharyngeal Cancer | Radiology | Skin Cancer | Squamous Cell Carcinoma | Stem Cell Therapy | Stem Cells | Study